SFA Therapeutics, Inc
A Major Advancement in Treating Chronic Inflammatory Diseases
SFA Therapeutics is a biotech with a novel immunomodulatory platform focused on chronic inflammatory diseases and cancer. Our vision is to change the practice of Medicine. Our drugs that modulate the immune system, downregulating NF-kB and RAS, controlling inflammation and cancer. Primary targets include psoriasis and liver diseases, e.g. Hepatitis B, NASH, liver cancer,. Other potential targets are uveitis, CLL/AML, and CAR-T side effects.